A Study to Find Out if the Medicine Called Rimegepant is Safe for Adults in India

by | Jul 10, 2026 | Clinical Trials | 0 comments

​ Conditions: Acute Treatment of Migraine

Interventions: Drug: Rimegepant 75 mg ODT

Sponsors: Pfizer

Not yet recruiting Conditions: Acute Treatment of Migraine
Interventions: Drug: Rimegepant 75 mg ODT
Sponsors: Pfizer
Not yet recruiting 

Submit a Comment

Your email address will not be published. Required fields are marked *